>유럽 생명공학 시장, 제품 유형(기기, 시약 및 서비스 및 소프트웨어), 기술( 나노 생명공학, PCR 기술, DNA 시퀀싱, 크로마토그래피 , 조직 공학 및 재생, 세포 기반 분석, 발효 및 기타), 응용 분야(생물 약학, 생물 산업, 생물 서비스, 생물정보학 및 생물 농업), 최종 사용자(제약 및 생명공학 회사, 계약 연구 기관, 학계 및 연구 기관 및 기타), 유통 채널(직접 입찰, 제3자 유통업체 및 기타), 국가(독일, 이탈리아, 영국, 프랑스, 스페인, 네덜란드, 벨기에, 스위스, 터키, 러시아, 유럽의 기타 지역) 산업 동향 및 2028년까지의 예측.
시장 분석 및 통찰력: 유럽 생명공학 시장
생명공학 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 27.9%의 CAGR로 성장하고 있으며 2028년까지 2,691,409.16백만 달러에 도달할 것으로 예상한다고 분석했습니다. 만성 질환의 유병률이 증가함에 따라 첨단 생명공학 제품과 도구가 필요하며 이는 생명공학 시장 성장을 촉진하는 요인입니다.
생명공학은 생물학적 시스템, 생물체 또는 이의 일부를 활용하여 다양한 제품을 개발하거나 만드는 기술입니다. 빵을 양조하고 굽는 것은 생명공학(효모(생물체)를 사용하여 원하는 제품을 생산하는 것)의 개념에 속하는 프로세스의 예입니다. 이러한 전통적인 프로세스는 일반적으로 생물체를 자연 그대로 활용하거나(또는 번식을 통해 더욱 발전시키는) 반면, 보다 현대적인 형태의 생명공학은 일반적으로 생물학적 시스템이나 생물체의 보다 진보된 수정을 포함합니다. 오늘날 생명공학은 다양한 분야(예: 유전학, 생화학, 분자생물학 등)를 포괄합니다. 의학(신약 및 치료법 개발), 농업(유전자 변형 식물, 바이오연료, 생물학적 처리 개발), 산업 생명공학(화학 물질, 종이, 섬유 및 식품 생산) 분야에서 매년 새로운 기술과 제품이 개발됩니다.
생명공학 시장은 만성 질환의 증가와 기술 발전의 증가로 인해 성장하고 있습니다. 게다가 제품 승인의 증가는 생명공학 시장 성장을 가속화하는 또 다른 요인입니다. 숙련된 전문가의 부족은 글로벌 생명공학 시장 성장을 제한할 것으로 예상됩니다.
생명공학 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 생명공학 시장 시나리오를 이해하려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 요청하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.
생명공학 시장 범위 및 시장 규모
생명공학 시장은 제품 유형, 기술, 응용 분야, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다. 세그먼트 간 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
- 제품 유형에 따라 생명공학 시장은 기기, 시약, 서비스 및 소프트웨어로 세분화됩니다. 2021년에는 다양한 혁신적 솔루션의 가용성으로 인해 기기 부문이 생명공학 시장을 지배할 것으로 예상됩니다.
- 기술에 따라 생명공학 시장은 나노바이오기술, PCR 기술, DNA 시퀀싱, 크로마토그래피, 조직 공학 및 재생, 세포 기반 분석, 발효 등으로 세분화됩니다. 2021년에는 나노바이오기술 부문이 광범위한 응용 분야로 인해 생명공학 시장을 지배할 것으로 예상됩니다.
- 응용 프로그램을 기준으로, 생명공학 시장은 생물약학, 생물산업, 생물서비스, 생물정보학, 생물농업으로 세분화됩니다. 2021년에는 연구 개발 활동이 증가함에 따라 생물약학 부문이 생명공학 시장을 지배할 것으로 예상됩니다.
- 최종 사용자를 기준으로 생명공학 시장은 제약 및 생명공학 회사, 계약 연구 기관, 학술 및 연구 기관 등으로 세분화됩니다. 2021년에는 다양한 의료 기관과 정부 기관이 연구 활동을 장려하기 위해 주도적인 활동을 늘리면서 제약 및 생명공학 회사 부문이 생명공학 시장을 지배할 것으로 예상됩니다.
- 유통 채널을 기준으로 생명공학 시장은 직접 입찰, 제3자 유통업체 및 기타로 세분화됩니다. 2021년에는 생명공학 기기에 대한 수요가 증가함에 따라 직접 입찰 부문이 생명공학 시장을 지배할 것으로 예상됩니다.
생명공학 시장 국가 수준 분석
위에 언급된 대로 국가, 제품 유형, 기술, 응용 분야, 최종 사용자 및 유통 채널별로 생명공학 시장을 분석하고 시장 규모 정보를 제공합니다.
생명공학 시장 보고서에서 다루는 국가는 영국, 독일, 프랑스, 스페인, 이탈리아, 네덜란드, 스위스, 러시아, 터키, 오스트리아, 아일랜드 및 기타 유럽 국가입니다.
독일은 생명공학 제품과 소프트웨어에 대한 연구 개발을 확대하면서 유럽 시장을 장악하고 있습니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
주요 시장 참여자들의 생명공학에 대한 인식을 높이기 위한 전략적 활동이 확대되면서 시장 성장이 촉진되고 있습니다.
생명공학 시장은 또한 특정 시장에서 모든 국가 성장에 대한 자세한 시장 분석을 제공합니다. 또한 시장 참여자의 전략과 지리적 입지에 대한 자세한 정보를 제공합니다. 데이터는 2010년부터 2019년까지의 과거 기간에 대해 제공됩니다.
경쟁 환경 및 생명공학 시장 점유율 분석
생명공학 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭과 폭, 응용 분야 우세, 기술 수명선 곡선이 포함됩니다. 위에 제공된 데이터 포인트는 생명공학 시장과 관련된 회사의 초점에만 관련됩니다.
생명공학을 다루는 주요 기업으로는 Trinity Biotech, Thermo Fisher Scientific Inc., Abbott, F. Hoffmann-La Roche Ltd, Charles River Laboratories, Eurofins Scientific, Promega Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Takara Bio Inc., Ortho Clinical Diagnostics, QIAGEN, Agilent Technologies, Inc., AstraZeneca, Merck KGaA, bioMérieux SA, Myriad Genetics, Inc., Illumina, Inc., Pacific Biosciences of California, Inc., Biogen 등이 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁사에 대한 경쟁 분석을 별도로 제공합니다.
또한 전 세계 여러 회사에서 많은 계약과 협정이 체결되면서 생명공학 시장이 가속화되고 있습니다.
예를 들어,
- 2021년 2월 Thermo Fisher Scientific Inc.는 이전에 발표한 Mesa Biotech, Inc. 인수를 완료했다고 발표했습니다. 이 인수는 생명공학 시장에서 회사의 리더십을 강화할 것으로 예상됩니다.
- 2021년 3월, Charles River Laboratories는 독점적인 세포 마이크로어레이 기술을 활용한 특수 생물분석 서비스를 제공하는 초기 단계 계약 연구 기관(CRO)인 Retrogenix Limited를 인수했다고 발표했습니다. 이 인수는 회사의 생물분석 사업 부문을 강화할 것으로 예상됩니다.
협력, 제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 시장 참여자의 기타 전략을 통해 생명공학 시장에서 회사의 입지를 강화하고 조직의 수익 성장에도 도움이 됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE BIOTECHNOLOGY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 EUROPE BIOTECHNOLOGY MARKET: REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING GERIATRIC POPULATION
5.1.2 GROWING PREVALENCE OF CHRONIC DISEASES
5.1.3 INCREASING TECHNOLOGICAL ADVANCEMENTS
5.1.4 WIDE RANGE OF APPLICATION
5.1.5 RISING FUNDING AND INVESTMENTS FOR THE DEVELOPMENT OF BIOTECHNOLOGY TECHNIQUES
5.2 RESTRAINTS
5.2.1 GROWING PACE OF PRODUCT RECALL
5.2.2 HIGH COST OF BIOTECHNOLOGY INSTRUMENT
5.2.3 STRICT REGULATORY FRAMEWORK
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MAJOR MARKET PLAYERS
5.3.2 ESCALATION IN INNOVATION AND TECHNOLOGIES
5.3.3 RISING EXPENDITURE ON HEALTHCARE
5.4 CHALLENGES
5.4.1 SHORTAGE OF SKILLED PERSONNEL
5.4.2 LIMITATIONS OF DOWNSTREAM PURIFICATION
6 IMPACT OF COVID-19 ON THE EUROPE BIOTECHNOLOGY MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY CHAIN
6.4 STRATEGIC DECISIONS BY MANUFACTURERS
6.5 CONCLUSION
7 EUROPE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 INSTRUMENT
7.3 REAGENTS
7.4 SERVICES & SOFTWARE
8 EUROPE BIOTECHNOLOGY MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 NANO BIOTECHNOLOGY
8.3 NANOCRYSTALS
8.4 NANOPARTICLES
8.5 LIPOSOMES
8.6 MICELLES
8.7 OTHERS
8.8 PCR TECHNOLOGY
8.9 CONVENTIONAL PCR
8.1 REAL-TIME PCR (QPCR)
8.11 DIGITAL PCR (DPCR)
8.12 REVERSE TRANSCRIPTION PCR (RT-PCR)
8.13 OTHER PCR
8.14 DNA SEQUENCING
8.15 SEQUENCING BY SYNTHESIS
8.16 ION SEMICONDUCTOR SEQUENCING
8.17 SEQUENCING BY LIGATION
8.18 PYROSEQUENCING
8.19 SINGLE MOLECULE REAL-TIME SEQUENCING
8.2 CHAIN TERMINATION SEQUENCING
8.21 NANOPORE SEQUENCING
8.22 CHROMATOGRAPHY
8.23 GAS CHROMATOGRAPHY
8.24 LIQUID CHROMATOGRAPHY
8.25 THIN LAYER CHROMATOGRAPHY
8.26 SUPERCRITICAL FLUID CHROMATOGRAPHY
8.27 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY/ULTRA HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC/UHPLC)
8.28 AFFINITY CHROMATOGRAPHY
8.29 TISSUE ENGINEERING AND REGENERATION
8.3 IMMUNOISOLATION TECHNOLOGY
8.31 CELL CULTURE TECHNOLOGY
8.32 STEM CELL TECHNOLOGY
8.33 CELL-BASED ASSAYS
8.34 FLOW CYTOMETRY
8.35 AUTOMATED HANDLING
8.36 LABEL-FREE-DETECTION
8.37 HIGH-THROUGHPUT SCREENING
8.38 OTHERS
8.39 FERMENTATION
8.4 UPSTREAM PROCESS
8.41 DOWNSTREAM PROCESS
8.42 OTHERS
9 EUROPE BIOTECHNOLOGY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BIOPHARMACY
9.3 BIOINDUSTRIAL
9.4 BIOSERVICES
9.5 BIOINFORMATICS
9.6 BIOAGRICULTURE
10 EUROPE BIOTECHNOLOGY MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 CONTRACT RESEARCH ORGANIZATIONS
10.4 ACADEMIC & RESEARCH INSTITUTES
10.5 OTHERS
11 EUROPE BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 EUROPE BIOTECHNOLOGY MARKET, BY REGION
12.1 EUROPE
12.1.1 GERMANY
12.1.2 FRANCE
12.1.3 U.K.
12.1.4 ITALY
12.1.5 SPAIN
12.1.6 BELGIUM
12.1.7 NETHERLANDS
12.1.8 RUSSIA
12.1.9 SWITZERLAND
12.1.10 TURKEY
12.1.11 AUSTRIA
12.1.12 NORWAY
12.1.13 HUNGARY
12.1.14 LITHUANIA
12.1.15 IRELAND
12.1.16 POLAND
12.1.17 REST OF EUROPE
13 EUROPE BIOTECHNOLOGY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 THERMO FISHER SCIENTIFIC INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 F. HOFFMANN-LA ROCHE LTD
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ASTRAZENECA
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 MERCK KGAA
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 ABBOTT
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 AGILENT TECHNOLOGIES, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BIOGEN
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 BIOMÉRIEUX SA
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 BIO-RAD LABORATORIES, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENTS
15.1 CHARLES RIVER LABORATORIES
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 EUROFINS SCIENTIFIC
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 ILLUMINA, INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 MYRIAD GENETICS, INC.
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 ORTHO CLINICAL DIAGNOSTICS.
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENTS
15.15 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 PERKINELMER INC.
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 PROMEGA CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.18 TAKARA BIO INC.
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 TRINITY BIOTECH
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 QIAGEN
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
표 목록
TABLE 1 EUROPE CANCER INCIDENCE IN BOTH THE GENDERS (2018)
TABLE 2 EUROPE CANCER INCIDENCE IN MEN (2018)
TABLE 3 EUROPE CANCER INCIDENCE IN WOMEN (2018)
TABLE 4 EUROPE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 5 EUROPE INSTRUMENTS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 EUROPE REAGENTS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 EUROPE SERVICES & SOFTWARE IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 EUROPE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 9 EUROPE NANO BIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 EUROPE NANO BIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 11 EUROPE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 EUROPE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 13 EUROPE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 EUROPE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 15 EUROPE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 EUROPE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 17 EUROPE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 EUROPE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 19 EUROPE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 EUROPE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 21 EUROPE FERMENTATION IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 EUROPE FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 23 EUROPE OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 EUROPE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 EUROPE BIOPHARMACY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 EUROPE BIOINDUSTRIAL IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 EUROPE BIOSERVICES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 EUROPE BIOINFORMATICS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 EUROPE BIOAGRICULTURE IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 EUROPE BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 31 EUROPE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 EUROPE ACADEMIC & RESEARCH INSTITUTES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 EUROPE OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 EUROPE BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 36 EUROPE DIRECT TENDER IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 EUROPE THIRD PARTY DISTRIBUTORS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 EUROPE OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 EUROPE BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 40 EUROPE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 41 EUROPE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 42 EUROPE FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 43 EUROPE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 44 EUROPE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 45 EUROPE NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 46 EUROPE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 47 EUROPE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 48 EUROPE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 49 EUROPE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 EUROPE BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 EUROPE BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 GERMANY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 53 GERMANY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 54 GERMANY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 55 GERMANY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 56 GERMANY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 57 GERMANY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 58 GERMANY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 59 GERMANY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 60 GERMANY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 61 GERMANY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 62 GERMANY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 63 GERMANY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 64 FRANCE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 65 FRANCE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 66 FRANCE FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 67 FRANCE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 68 FRANCE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 69 FRANCE NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 70 FRANCE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 71 FRANCE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 72 FRANCE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 73 FRANCE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 74 FRANCE BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 75 FRANCE BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 76 U.K. BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 77 U.K. BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 78 U.K. FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 79 U.K. TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 80 U.K. PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 81 U.K. NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 82 U.K. CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 83 U.K. DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 84 U.K. CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 85 U.K. BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 U.K. BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 87 U.K. BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 88 ITALY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 89 ITALY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 90 ITALY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 91 ITALY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 92 ITALY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 93 ITALY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 94 ITALY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 95 ITALY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 96 ITALY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 97 ITALY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 98 ITALY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 99 ITALY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 100 SPAIN BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 101 SPAIN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 102 SPAIN FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 103 SPAIN TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 104 SPAIN PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 105 SPAIN NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 106 SPAIN CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 107 SPAIN DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 108 SPAIN CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 109 SPAIN BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 110 SPAIN BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 111 SPAIN BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 112 BELGIUM BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 113 BELGIUM BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 114 BELGIUM FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 115 BELGIUM TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 116 BELGIUM PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 117 BELGIUM NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 118 BELGIUM CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 119 BELGIUM DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 120 BELGIUM CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 121 BELGIUM BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 122 BELGIUM BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 123 BELGIUM BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 124 NETHERLANDS BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 125 NETHERLANDS BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 126 NETHERLANDS FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 127 NETHERLANDS TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 128 NETHERLANDS PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 129 NETHERLANDS NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 130 NETHERLANDS CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 131 NETHERLANDS DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 132 NETHERLANDS CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 133 NETHERLANDS BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 134 NETHERLANDS BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 135 NETHERLANDS BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 136 RUSSIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 137 RUSSIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 138 RUSSIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 139 RUSSIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 140 RUSSIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 141 RUSSIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 142 RUSSIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 143 RUSSIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 144 RUSSIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 145 RUSSIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 146 RUSSIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 147 RUSSIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 148 SWITZERLAND BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 149 SWITZERLAND BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 150 SWITZERLAND FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 151 SWITZERLAND TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 152 SWITZERLAND PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 153 SWITZERLAND NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 154 SWITZERLAND CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 155 SWITZERLAND DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 156 SWITZERLAND CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 157 SWITZERLAND BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 158 SWITZERLAND BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 159 SWITZERLAND BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 160 TURKEY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 161 TURKEY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 162 TURKEY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 163 TURKEY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 164 TURKEY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 165 TURKEY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 166 TURKEY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 167 TURKEY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 168 TURKEY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 169 TURKEY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 170 TURKEY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 171 TURKEY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 172 AUSTRIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 173 AUSTRIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 174 AUSTRIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 175 AUSTRIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 176 AUSTRIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 177 AUSTRIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 178 AUSTRIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 179 AUSTRIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 180 AUSTRIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 181 AUSTRIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 182 AUSTRIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 183 AUSTRIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 184 NORWAY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 185 NORWAY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 186 NORWAY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 187 NORWAY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 188 NORWAY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 189 NORWAY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 190 NORWAY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 191 NORWAY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 192 NORWAY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 193 NORWAY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 194 NORWAY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 195 NORWAY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 196 HUNGARY BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 197 HUNGARY BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 198 HUNGARY FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 199 HUNGARY TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 200 HUNGARY PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 201 HUNGARY NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 202 HUNGARY CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 203 HUNGARY DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 204 HUNGARY CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 205 HUNGARY BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 206 HUNGARY BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 207 HUNGARY BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 208 LITHUANIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 209 LITHUANIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 210 LITHUANIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 211 LITHUANIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 212 LITHUANIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 213 LITHUANIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 214 LITHUANIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 215 LITHUANIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 216 LITHUANIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 217 LITHUANIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 218 LITHUANIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 219 LITHUANIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 220 IRELAND BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 221 IRELAND BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 222 IRELAND FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 223 IRELAND TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 224 IRELAND PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 225 IRELAND NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 226 IRELAND CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 227 IRELAND DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 228 IRELAND CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 229 IRELAND BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 230 IRELAND BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 231 IRELAND BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 232 POLAND BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 233 POLAND BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 234 POLAND FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 235 POLAND TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 236 POLAND PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 237 POLAND NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 238 POLAND CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 239 POLAND DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 240 POLAND CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 241 POLAND BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 242 POLAND BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 243 POLAND BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 244 REST OF EUROPE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
그림 목록
FIGURE 1 EUROPE BIOTECHNOLOGY MARKET: SEGMENTATION
FIGURE 2 EUROPE BIOTECHNOLOGY MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE BIOTECHNOLOGY MARKET: DROC ANALYSIS
FIGURE 4 EUROPE BIOTECHNOLOGY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE BIOTECHNOLOGY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE BIOTECHNOLOGY MARKET: MULTIVARIATE MODELLING
FIGURE 7 EUROPE BIOTECHNOLOGY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 EUROPE BIOTECHNOLOGY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE BIOTECHNOLOGY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE BIOTECHNOLOGY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 EUROPE BIOTECHNOLOGY MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE BIOTECHNOLOGY MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 GROWING PREVALENCE OF CHRONIC DISEASES IS DRIVING THE EUROPE BIOTECHNOLOGY MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 INSTRUMENTS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE BIOTECHNOLOGY MARKET IN 2021 & 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE BIOTECHNOLOGY MARKET
FIGURE 16 CANCER DEATH RATES BY AGE GROUP (2017)
FIGURE 17 NUMBER OF NEW CANCER CASES FOR ALL AGE GROUPS (IN 2018)
FIGURE 18 NUMBER OF NEW CASES IN MALES FOR ALL AGE GROUPS (IN 2018)
FIGURE 19 NUMBER OF NEW CASES IN FEMALES FOR ALL AGE GROUPS (IN 2018)
FIGURE 20 EUROPE BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, 2020
FIGURE 21 EUROPE BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 22 EUROPE BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 23 EUROPE BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 EUROPE BIOTECHNOLOGY MARKET : BY TECHNOLOGY, 2020
FIGURE 25 EUROPE BIOTECHNOLOGY MARKET : BY TECHNOLOGY, 2021-2028 (USD MILLION)
FIGURE 26 EUROPE BIOTECHNOLOGY MARKET : BY TECHNOLOGY, CAGR (2021-2028)
FIGURE 27 EUROPE BIOTECHNOLOGY MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 28 EUROPE BIOTECHNOLOGY MARKET : BY APPLICATION, 2020
FIGURE 29 EUROPE BIOTECHNOLOGY MARKET : BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 30 EUROPE BIOTECHNOLOGY MARKET : BY APPLICATION, CAGR (2021-2028)
FIGURE 31 EUROPE BIOTECHNOLOGY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 32 EUROPE BIOTECHNOLOGY MARKET: BY END USER, 2020
FIGURE 33 EUROPE BIOTECHNOLOGY MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 34 EUROPE BIOTECHNOLOGY MARKET: BY END USER, CAGR (2021-2028)
FIGURE 35 EUROPE BIOTECHNOLOGY MARKET: BY END USER, LIFELINE CURVE
FIGURE 36 EUROPE BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 37 EUROPE BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 38 EUROPE BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 39 EUROPE BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 EUROPE BIOTECHNOLOGY MARKET: SNAPSHOT (2020)
FIGURE 41 EUROPE BIOTECHNOLOGY MARKET: BY COUNTRY (2020)
FIGURE 42 EUROPE BIOTECHNOLOGY MARKET: BY COUNTRY (2021 & 2028)
FIGURE 43 EUROPE BIOTECHNOLOGY MARKET: BY COUNTRY (2020 & 2028)
FIGURE 44 EUROPE BIOTECHNOLOGY MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 45 EUROPE BIOTECHNOLOGY MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
